首页> 外文期刊>Free Radical Biology and Medicine: The Official Journal of the Oxygen Society >Radical-induced DNA damage by cytotoxic square-planar copper(II) complexes incorporating o-phthalate and 1,10-phenanthroline or 2,2′-dipyridyl
【24h】

Radical-induced DNA damage by cytotoxic square-planar copper(II) complexes incorporating o-phthalate and 1,10-phenanthroline or 2,2′-dipyridyl

机译:加入邻苯二甲酸酯和1,10-菲咯啉或2,2'-联吡啶的细胞毒性方形-平面铜(II)配合物对自由基的DNA损伤

获取原文
获取原文并翻译 | 示例
           

摘要

DNA-targeting copper(II) reagents have emerged as suitable drug candidates owing to the clinical success of the copper-activated, natural chemotherapeutic drug bleomycin. This agent and the synthetic chemical nuclease copper(II) bis-1,10-phenanthroline represent important templates for inorganic drug design owing to their ability to initiate free radical DNA scission. Herein, we report the synthesis and biological properties of 1:1:1 square-planar copper(II) complexes incorporating the dicarboxylate o-phthalate and 1,10-phenanthroline (1) or 2,2′-dipyridyl (2) ligands. Their broad-spectrum chemotherapeutic potential has been assessed at 24- and 96-h intervals, along with that of the clinical agent cisplatin, using breast (MCF-7), prostate (DU145), colon (HT29), and intrinsically cisplatin-resistant ovarian (SK-OV-3) human cancer cells. 1 represents a potent cytotoxic agent with IC 50 values ranging from 5.6 to 3.4 μM across all cell lines, including SK-OV-3. The production of endogenous reactive oxygen species within SK-OV-3 cancer cells was monitored using the fluorophore 2′,7′-dichlorodihydrofluorescin diacetate, and results indicate a concentration-dependent propensity toward ROS generation by 1 and 2 that mirrors their antitumoral behavior. DNA interaction studies, using fluorescence and viscosity measurements, were conducted in tandem with the DNA-targeting drugs actinomycin D and pentamidine, using calf thymus DNA, poly[d(A-T) 2], and poly[d(G-C) 2], with intercalation of 1 and 2 at the minor groove appearing to be the likely interaction mode. DNA cleavage reactions using superhelical plasmid DNA, in the presence of exogenous reductant, l-ascorbic acid, revealed excellent agreement between double-stranded DNA scission capability and antitumoral IC 50 concentration. The presence of double-strand DNA breaks (DSBs) was confirmed within SK-OV-3 cancer cells using immunodetection of γ-H2AX foci by confocal microscopy and flow cytometry, with complex 1 quantitatively producing superior numbers of DSBs compared with complex 2. Superoxide dismutase and catalase mimetic activity assays were conducted, and these activities are related to the ability of both complexes to cleave DNA through free radical generation.
机译:由于铜激活的天然化疗药物博来霉素的临床成功,靶向DNA的铜(II)试剂已成为合适的候选药物。该试剂和合成的化学核酸酶双(1,1-二氧杂菲)铜(II)铜由于其能够引发自由基DNA断裂而成为无机药物设计的重要模板。在这里,我们报告的合成和生物学特性结合二羧酸邻苯二甲酸酯和1,10-菲咯啉(1)或2,2'-联吡啶(2)配体的1:1:1方平面铜(II)配合物。已使用乳腺癌(MCF-7),前列腺癌(DU145),结肠(HT29)和固有的顺铂耐药性,在24和96小时的间隔内以及临床药物顺铂评估了它们的广谱化疗潜力卵巢(SK-OV-3)人类癌细胞。 1表示有效的细胞毒剂,包括SK-OV-3在内的所有细胞系的IC 50值范围为5.6至3.4μM。使用荧光基团2',7'-二氯二氢荧光素二乙酸盐监测SK-OV-3癌细胞内源性活性氧的产生,结果表明1和2对ROS产生浓度依赖性,反映了它们的抗肿瘤行为。与DNA靶向药物放线菌素D和喷他idine,小牛胸腺DNA,poly [d(AT)2]和poly [d(GC)2]结合使用荧光和粘度测量进行DNA相互作用研究在小凹槽处插入1和2似乎是可能的交互方式。在存在外源还原剂1-抗坏血酸的情况下,使用超螺旋质粒DNA进行的DNA裂解反应揭示了双链DNA断裂能力与抗肿瘤IC 50浓度之间的极佳一致性。通过共聚焦显微镜和流式细胞术对γ-H2AX灶进行免疫检测,证实SK-OV-3癌细胞内存在双链DNA断裂(DSB),与复合物2相比,复合物1定量产生的DSB数量更高。进行了歧化酶和过氧化氢酶模拟活性测定,并且这些活性与两种复合物通过自由基产生切割DNA的能力有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号